The stereotypical law student's first day is summed up as follows: Students think they are entering the field for the public good while their neighbors are in it for a hefty paycheck. A study published in the Journal of General Internal Medicine indicates that medical students have a similar experience and found that while students and residents felt confident they could accept gifts from the pharmaceutical industry and remain unbiased, they couldn't say the same of their peers.
It is no secret that the long-term care industry has been a relatively late adapter of technological advancements. But interest from vendors, provider demand and a growing number of tech-savvy residents are helping to change the landscape.
What if compounding pharmacies were given even a quarter of the scrutiny of long-term care inspections? If that were done, I don't believe there would be a fungus among us!
Leading long-term care pharmacy provider Omnicare, which announced this week that it has ended its efforts to takeover competitor PharMerica, posted a profit in the fourth quarter.
Covidien plans to spin off its pharmaceuticals division into a separate company. The independent division can better compete in the growing pain-management area, the company announced. The drugs division generates more than $2 billion in sales each year. Among its products are Exalgo, a 24- hour extended release opioid, and Pennsaid, a topical anti-inflammatory medication. The company's medical products business has annual sales of about $9.6 billion, according to the firm.
A new antibiotic designed to treat the diarrhea that accompanies Clostridium difficile won unanimous support from a government medical panel convened by the U.S. Food and Drug Administration.
President Barack Obama Tuesday fielded questions about healthcare reform at a tele-town hall meeting sponsored by AARP, a powerful seniors advocacy group. He discussed living wills, Medicare Part D, and when he can expect his own AARP card.